TY - JOUR T1 - Factors affecting to quit smoking in an outpatient smoking cessation clinic JF - European Respiratory Journal JO - Eur Respir J VL - 38 IS - Suppl 55 SP - p1073 AU - Bedriye Atay Yayla AU - Ali Ihsan Yildiz AU - Güven Cosgun AU - Erhan Ugurlu AU - Fatma Evyapan Y1 - 2011/09/01 UR - http://erj.ersjournals.com/content/38/Suppl_55/p1073.abstract N2 - Aim: Majority of the smokers intend to stop smoking. But success rate is low and is affected by many factors. Our aim is to determine the rate of the smoking cessation and the factors affecting the success of our smoking cessation outpatient clinic.Material and methods: We evaluated 201 people admitted to our smoking cessation clinic between February 2009- February 2011. Patients reevaluated at the end of 2 years by phone call.Results: Patients mean age was: 44,18±13; 69,1% male,30,9 were female with mean 28,95±20,82 pack-years of smoking status. Majority (92,2%) had complaints related to smoking: dyspnea (58,8), sputum (75,5%), halithosis (63,7) 89,7% of the had already unsuccessful attempt to quit. Fagerström test showed that 45,6% > 6. At the end of 2 years we could reach 128 patients.There were no difference between the responders and unreached patients according to age, sex, presence of co-morbid diseases, smoking status and tobacco addiction status. The rate of the patients who stopped smoking was 21,8% after 2 years.Patients with higher Fagerström test values (6 > pts) had higher rate of stop smoking (p=0,037); dyslipidemia was the commonest co-morbiditiy among quitters (42,3% p=0,014), patients with >1 follow-up visits had higher rate of quit smoking (p=0,005). Vareniclin was superior (39,3%) to NRT (7,1%) (p < 0,05).Conclusions: The rate of smoking cessation is mainly affected by the patients tobacco addiction levels, patients concern of potential cardiovascular co-morbidities, and patients determination especially to the requested follow-up visits. Vareniclin is found to be superior to the NRT. Failure of health care professionals (0%) deserved further concern. ER -